Ai Neuro Oncology

Brain Tumour Biology

Doctoral work examines the biological mechanisms driving nervous system tumours. Biological understanding underpins every treatment approach in this field.

Glioma Biology Research

Research examines tumours arising from the supporting cells of the brain. Gliomas are the commonest primary brain tumours affecting adult patients.

Glioblastoma Biology

Doctoral study examines the most aggressive form of adult brain tumour. Survival for this tumour has improved only marginally over recent decades.

Lower Grade Glioma Biology

Research examines slower growing tumours of the brain supporting cells. These tumours affect younger adults and eventually progress in most patients.

Oligodendroglial Tumour Research

Doctoral work examines a molecularly defined tumour with distinctive behaviour. This tumour type responds unusually well to combined treatment approaches.

Astrocytic Tumour Research

Research examines tumours arising from a major supporting cell population. Molecular markers now define these tumours more reliably than appearance.

Ependymal Tumour Research

Doctoral study examines tumours arising from cells lining brain cavities. These tumours behave very differently according to where they arise.

Medulloblastoma Biology

Research examines the commonest malignant brain tumour affecting children. Molecular subgrouping has transformed how this tumour is treated.

Embryonal Tumour Research

Doctoral work examines aggressive childhood tumours resembling developing tissue. These tumours require intensive treatment and affect very young children.

Meningioma Biology

Research examines tumours arising from the membranes covering the brain. Most are slow growing yet a small minority behave very aggressively indeed.

Pituitary Tumour Research

Doctoral study examines tumours of the hormone producing gland beneath the brain. These tumours cause hormonal disturbance alongside local pressure effects.

Nerve Sheath Tumour Research

Research examines tumours arising from the coverings of nerves. These tumours cause hearing loss and balance disturbance when affecting cranial nerves.

Germ Cell Tumour Research

Doctoral work examines a distinctive tumour group arising in young people. Several of these tumours are curable with appropriate combined treatment.

Nervous System Lymphoma Research

Research examines lymphoid tumours arising within the nervous system. These tumours require entirely different treatment from other brain tumours.

Rare Tumour Type Research

Doctoral study examines uncommon nervous system tumours affecting few patients. Rare tumours lack the evidence base that common tumours possess.

Cell Of Origin Research

Research examines which normal cells give rise to particular tumours. Origin determines tumour behaviour and suggests vulnerabilities to exploit.

Cancer Stem Cell Research

Doctoral work examines tumour cells capable of regenerating the whole tumour. These cells resist treatment and are implicated in tumour return.

Tumour Heterogeneity Research

Research examines molecular differences between cells within one tumour. Heterogeneity explains why treatments targeting single mechanisms fail.

Spatial Heterogeneity Research

Doctoral study examines how tumour biology differs across regions of one tumour. Single biopsies capture only a fraction of the tumour biology present.

Clonal Evolution Research

Research examines how tumour cell populations change during treatment. Evolutionary understanding explains why tumours return resistant to treatment.

Tumour Microenvironment Research

Doctoral work examines the surrounding tissue supporting tumour growth. The environment is now recognised as a target alongside the tumour cells.

Immune Microenvironment Research

Research examines immune cells present within nervous system tumours. Brain tumours are characteristically poor at attracting immune attack.

Microglial Interaction Research

Doctoral study examines resident brain immune cells interacting with tumours. These cells frequently support rather than oppose tumour growth.

Astrocyte Tumour Interaction

Research examines supporting brain cells interacting with adjacent tumour tissue. These cells can protect tumour cells from the treatments applied.

Vascular Biology In Tumours

Doctoral work examines abnormal blood vessels formed within brain tumours. Vessel abnormality causes both swelling and poor treatment delivery.

Angiogenesis Research

Research examines tumours recruiting new blood vessels to support growth. Vessel formation was an early and only partially successful treatment target.

Hypoxia Research

Doctoral study examines tumour regions receiving insufficient oxygen supply. Oxygen deprived regions resist radiation and drive aggressive behaviour.

Metabolic Reprogramming Research

Research examines how tumour cells change their energy generation strategy. Metabolic differences offer potential vulnerabilities for treatment.

Metabolite Oncogenesis Research

Doctoral work examines abnormal metabolic products driving tumour development. This mechanism defines a major molecular class of adult glioma.

Epigenetic Dysregulation Research

Research examines disturbed gene regulation within nervous system tumours. Regulatory disturbance is central to several childhood tumour types.

Methylation Classification Research

Doctoral study examines classifying tumours by their chemical mark patterns. Mark based classification has revealed entirely new tumour categories.

Chromatin Dysregulation Research

Research examines disturbed genome packaging within tumour cells. Packaging disturbance drives several tumours affecting children and young adults.

Genomic Change Research

Doctoral work examines genome sequence changes present within brain tumours. Genomic characterisation now guides diagnosis and treatment selection.

Chromosomal Loss Research

Research examines whole chromosome arms missing from tumour cell genomes. Combined loss of two specific arms defines an important glioma subtype.

Gene Amplification Research

Doctoral study examines genes present in greatly increased copy numbers. Amplification is common in aggressive tumours and offers treatment targets.

Fusion Gene Research

Research examines genes abnormally joined together within tumour genomes. Several fusions are directly targetable with available treatments.

Signalling Pathway Research

Doctoral work examines molecular communication pathways driving tumour growth. Pathway understanding directs development of targeted treatments.

Growth Factor Signalling Research

Research examines growth promoting signals frequently overactive in tumours. These pathways were among the earliest targets pursued in this field.

Cell Cycle Dysregulation

Doctoral study examines loss of normal control over tumour cell division. Cycle control loss is nearly universal across aggressive brain tumours.

Programmed Cell Death Resistance

Research examines tumour cells evading normal mechanisms of programmed cell death. Death resistance underlies much of the treatment failure observed.

Invasion And Migration Research

Doctoral work examines tumour cells spreading into surrounding healthy brain tissue. Diffuse spread is the reason complete surgical removal is impossible.

Invasion Route Research

Research examines the anatomical routes along which tumour cells migrate. Cells travel along vessels and nerve fibre pathways preferentially.

Neuronal Tumour Interaction

Doctoral study examines nerve cells interacting directly with tumour tissue. Neural activity has been shown to actively promote tumour growth.

Synaptic Integration Research

Research examines tumour cells forming connections with surrounding neurons. Connection formation represents a genuinely novel treatment target.

Electrical Activity In Tumours

Doctoral work examines electrical signalling within and around brain tumours. Electrical activity links seizure generation with tumour progression.

Extracellular Vesicle Research

Research examines small particles released by tumour cells into surroundings. These particles carry signals and offer potential diagnostic markers.

Tumour Immune Evasion

Doctoral study examines how tumours escape recognition by the immune system. Evasion mechanisms explain why immune treatments have disappointed here.

Barrier Biology In Tumours

Research examines the protective brain barrier within and around tumours. The barrier prevents most treatments reaching tumour cells adequately.

Brain Metastasis Research

Doctoral work examines cancers spreading to the brain from elsewhere in the body. Secondary brain tumours are far commoner than primary brain tumours.

Leptomeningeal Spread Research

Research examines tumour spreading through the fluid surrounding brain and cord. This pattern of spread carries a particularly poor clinical outlook.

Tumour Classification Research

Doctoral study examines how nervous system tumours are categorised. Classification determines both prognosis and which treatment is offered.

Molecular Classification Research

Research examines grouping tumours by their molecular characteristics. Molecular grouping has largely superseded appearance based categories.

Integrated Diagnosis Research

Doctoral work examines diagnoses combining appearance with molecular findings. Integration improves consistency between differing pathology departments.

Histopathology Research

Research examines microscopic examination of tumour tissue samples. Tissue examination remains fundamental despite molecular testing advances.

Digital Pathology Research

Doctoral study examines digitised examination of tumour tissue slides. Digital slides permit sharing, quantification and automated analysis.

Automated Pathology Research

Research examines automated interpretation of tumour tissue images. Automation could address the worldwide shortage of specialist pathologists.

Intraoperative Diagnosis Research

Doctoral work examines rapid tissue diagnosis during ongoing surgery. Rapid diagnosis guides how extensive the operation should actually be.

Rapid Molecular Diagnosis

Research examines obtaining molecular results within surgical timeframes. Rapid molecular information could change decisions made during surgery.

Immunohistochemistry Research

Doctoral study examines antibody based staining identifying tumour proteins. Staining provides molecular information at very modest laboratory cost.

Sequencing In Diagnosis

Research examines genome sequencing used within tumour diagnostic practice. Sequencing identifies targetable changes alongside diagnostic markers.

Methylation Profiling Diagnosis

Doctoral work examines chemical mark profiling used for tumour diagnosis. Profiling reclassifies a meaningful proportion of submitted cases.

Copy Number Profiling Research

Research examines measuring genome regions gained or lost in tumours. Copy number patterns support both diagnosis and prognostic assessment.

Diagnostic Reproducibility Research

Doctoral study examines agreement between pathologists examining identical tissue. Disagreement was substantial before molecular criteria were introduced.

Grading Practice Research

Research examines assigning aggressiveness grades to nervous system tumours. Grading criteria have shifted substantially toward molecular features.

Prognostic Marker Research

Doctoral work examines markers indicating likely outcome regardless of treatment. Prognostic information shapes discussion and planning with patients.

Predictive Marker Research

Research examines markers indicating who will benefit from specific treatment. Predictive markers permit avoiding treatments unlikely to help.

Liquid Biopsy Research

Doctoral study examines detecting tumour material within body fluids. Fluid based detection could reduce reliance on repeated tissue sampling.

Cerebrospinal Fluid Analysis

Research examines analysing the fluid surrounding the brain for tumour markers. This fluid contains far more tumour material than blood does.

Circulating Tumour Material Research

Doctoral work examines tumour derived material detectable within blood. Blood detection is difficult because the brain barrier limits release.

Biopsy Technique Research

Research examines obtaining tumour tissue safely for diagnostic examination. Technique determines both diagnostic yield and procedural risk.

Stereotactic Biopsy Research

Doctoral study examines precisely guided sampling of deep brain tumours. Guided sampling reaches tumours that open surgery cannot safely access.

Diagnostic Imaging Research

Research examines imaging used to detect and characterise brain tumours. Imaging determines the initial diagnosis and directs subsequent management.

Advanced Imaging In Diagnosis

Doctoral work examines specialised imaging characterising tumour biology. Advanced methods distinguish tumour types that conventional imaging cannot.

Perfusion Imaging Applications

Research examines imaging blood supply within nervous system tumours. Blood supply measurement helps distinguish tumour from treatment effect.

Spectroscopy Applications

Doctoral study examines measuring tumour chemistry without any tissue sampling. Chemical measurement can indicate tumour type before surgery occurs.

Amino Acid Imaging Research

Research examines tracer imaging showing tumour uptake of building blocks. This imaging distinguishes active tumour from treatment related change.

Radiomics Research

Doctoral work examines extracting quantitative features from tumour images. Extracted features may indicate molecular characteristics before surgery.

Imaging Molecular Prediction

Research examines predicting molecular tumour features from imaging alone. Noninvasive prediction could guide planning before any tissue is obtained.

Automated Segmentation Research

Doctoral study examines automatically outlining tumours within acquired images. Consistent outlining is essential for measuring change reliably.

Response Assessment Criteria

Research examines standardised rules for judging whether treatment is working. Criteria in this field have been repeatedly revised and remain imperfect.

Pseudoprogression Research

Doctoral work examines apparent worsening that actually reflects treatment effect. Misinterpretation leads to effective treatment being stopped prematurely.

Radiation Necrosis Research

Research examines brain tissue damage caused by the radiation treatment itself. This damage closely resembles tumour return on conventional imaging.

Treatment Effect Discrimination

Doctoral study examines distinguishing genuine tumour growth from treatment change. This distinction is among the hardest problems in this specialty.

Longitudinal Monitoring Research

Research examines tracking tumours across repeated imaging over long periods. Monitoring frequency balances early detection against patient burden.

Recurrence Detection Research

Doctoral work examines identifying tumour return as early as possible. Earlier detection permits treatment while more options remain available.

Multimodal Diagnostic Integration

Research examines combining imaging, tissue and molecular information together. Integration produces more reliable conclusions than any single source.

Diagnostic Delay Research

Doctoral study examines time from first symptoms to established diagnosis. Delays are common because early symptoms are vague and nonspecific.

Referral Pathway Research

Research examines routes by which patients reach specialist tumour services. Pathway design determines how quickly treatment can actually begin.

Multidisciplinary Team Research

Doctoral work examines teams combining specialties to plan tumour treatment. Team review measurably improves decisions in complex tumour cases.

Second Opinion Research

Research examines review of diagnoses by additional specialist centres. Specialist review changes the diagnosis in a meaningful proportion of cases.

Diagnostic Communication Research

Doctoral study examines how tumour diagnoses are conveyed to patients. Communication quality shapes understanding and lasting memory of the conversation.

Paediatric Diagnosis Research

Research examines diagnosing nervous system tumours arising in children. Childhood tumours differ fundamentally from those affecting adults.

Age Related Tumour Difference

Doctoral work examines why tumour types differ so greatly between age groups. Age differences reflect distinct developmental origins of these tumours.

Familial Syndrome Research

Research examines inherited conditions predisposing to nervous system tumours. Syndrome recognition affects surveillance for patients and their relatives.

Predisposition Testing Research

Doctoral study examines genetic testing for inherited tumour susceptibility. Testing informs family members and directs surveillance arrangements.

Neurosurgical Resection Research

Research examines surgical removal of nervous system tumours. Surgery provides tissue for diagnosis and improves survival for most tumour types.

Extent Of Resection Research

Doctoral work examines how much tumour removal improves patient outcome. Greater removal improves survival and must be balanced against function.

Awake Craniotomy Research

Research examines surgery performed while the patient remains awake. Awake surgery permits testing functions before tissue is finally removed.

Functional Preservation Research

Doctoral study examines protecting essential functions during tumour surgery. Preserving function matters as much to patients as removing tumour.

Intraoperative Imaging Research

Research examines imaging performed during ongoing tumour surgery. Imaging during surgery accounts for brain shifting once the skull is opened.

Fluorescence Guided Surgery

Doctoral work examines substances making tumour tissue glow during surgery. Visible marking measurably increases the amount of tumour removed.

Intraoperative Monitoring Research

Research examines monitoring nervous system function throughout tumour surgery. Monitoring warns surgeons before permanent damage has actually occurred.

Minimally Invasive Surgery Research

Doctoral study examines surgical approaches through very small openings. Smaller approaches reduce recovery time and surgical complication rates.

Laser Ablation Research

Research examines destroying tumour tissue using precisely guided laser energy. Ablation reaches tumours located too deep for conventional open surgery.

Surgical Outcome Research

Doctoral work examines results and complications following tumour surgery. Outcome measurement supports comparison between surgeons and centres.

Reoperation Research

Research examines further surgery when tumours return after treatment. Repeat surgery benefits selected patients and carries increased risk.

Radiotherapy Research

Doctoral study examines radiation treatment of nervous system tumours. Radiation is a component of treatment for most malignant brain tumours.

Fractionation Research

Research examines dividing radiation treatment into separate delivered sessions. Session structure balances tumour effect against healthy tissue damage.

Stereotactic Radiosurgery

Doctoral work examines highly focused radiation delivered in very few sessions. Focused delivery suits small well defined tumours particularly well.

Proton Therapy Research

Research examines radiation using protons rather than conventional photons. Proton delivery reduces radiation reaching healthy surrounding tissue.

Particle Therapy Research

Doctoral study examines heavier particles used for radiation treatment. Heavier particles may overcome resistance that photons cannot address.

Radiotherapy Planning Research

Research examines designing radiation treatment for individual patients. Planning precision determines how much healthy tissue receives radiation.

Target Volume Research

Doctoral work examines deciding which tissue volume should receive radiation. Volume definition must account for invisible microscopic tumour spread.

Normal Tissue Sparing Research

Research examines protecting healthy structures during radiation treatment. Sparing critical structures preserves function and cognitive ability.

Radiation Toxicity Research

Doctoral study examines harm caused by radiation treatment to the brain. Radiation toxicity can emerge long after treatment has been completed.

Cognitive Protection Research

Research examines preserving thinking ability during brain radiation treatment. Protecting memory structures measurably reduces cognitive decline.

Reirradiation Research

Doctoral work examines further radiation when tumours return after treatment. Repeat radiation is possible in selected patients with careful planning.

Radiosensitisation Research

Research examines treatments making tumours more vulnerable to radiation. Sensitisation could improve outcomes without increasing radiation given.

Chemotherapy Research

Doctoral study examines medicines used to treat nervous system tumours. Very few chemotherapy agents cross the barrier protecting the brain.

Alkylating Agent Research

Research examines the principal chemotherapy class used for brain tumours. These agents damage tumour genomes and benefit specific molecular subgroups.

Treatment Resistance Research

Doctoral work examines why tumours stop responding to given treatments. Resistance mechanisms are the central obstacle to improving survival.

Repair Pathway Research

Research examines tumour cells repairing damage caused by treatment. Repair capacity determines sensitivity to both radiation and chemotherapy.

Targeted Therapy Research

Doctoral study examines treatments acting on specific molecular tumour features. Targeted treatment requires molecular testing to identify candidates.

Kinase Inhibitor Research

Research examines medicines blocking specific signalling enzymes within tumours. Poor brain penetration has limited the success of many such agents.

Metabolic Inhibitor Research

Doctoral work examines treatments targeting abnormal tumour metabolism. Metabolic targeting has produced approved treatments for specific subgroups.

Epigenetic Therapy Research

Research examines treatments acting on gene regulation within tumour cells. Regulatory targeting suits tumours driven by genome packaging disturbance.

Antiangiogenic Therapy Research

Doctoral study examines treatments blocking tumour blood vessel formation. These treatments reduce swelling without clearly extending survival.

Immunotherapy Research

Research examines treatments working through the patient immune system. Immune treatments have so far disappointed in primary brain tumours.

Checkpoint Inhibition Research

Doctoral work examines releasing immune restraints on tumour attack. These treatments transformed other cancers and have not yet done so here.

Vaccine Therapy Research

Research examines treatments training the immune system against tumours. Vaccine approaches must overcome the immune suppression tumours create.

Cell Therapy Research

Doctoral study examines living cells administered as tumour treatment. Cell treatments must reach tumours behind the protective brain barrier.

Engineered Cell Therapy Research

Research examines immune cells modified to recognise tumour targets. Target selection is difficult because tumour markers vary within tumours.

Oncolytic Virus Research

Doctoral work examines viruses engineered to infect and destroy tumour cells. These viruses also provoke immune responses against the tumour.

Antibody Therapy Research

Research examines antibodies directed against tumour associated molecular targets. Antibodies enter the brain poorly and require delivery assistance.

Antibody Conjugate Research

Doctoral study examines antibodies carrying attached treatment molecules. Conjugates concentrate treatment specifically at tumour cell surfaces.

Radioligand Therapy Research

Research examines targeted molecules delivering radiation directly to tumours. Targeted radiation concentrates dose while sparing surrounding tissue.

Tumour Treating Fields Research

Doctoral work examines electrical fields applied to disturb tumour cell division. This approach extends survival modestly and requires continuous wear.

Convection Enhanced Delivery

Research examines infusing treatment directly into tumour tissue under pressure. Direct infusion bypasses the barrier limiting treatment entry.

Barrier Opening Research

Doctoral study examines temporarily opening the protective brain barrier. Controlled opening permits treatments to reach tumours far more effectively.

Intrathecal Therapy Research

Research examines treatment delivered into fluid surrounding brain and cord. This route suits tumour spreading through the surrounding fluid.

Local Delivery Research

Doctoral work examines treatment placed directly within the surgical cavity. Local placement achieves high concentration with minimal body exposure.

Nanoparticle Delivery Research

Research examines nanoscale carriers transporting treatment to brain tumours. Carriers aim to cross the barrier that free treatments cannot.

Combination Treatment Research

Doctoral study examines several treatment approaches used together. Combination addresses the tumour diversity that single treatments cannot.

Treatment Sequencing Research

Research examines the order in which available treatments are given. Sequencing affects both effectiveness and what options remain afterwards.

Adaptive Treatment Research

Doctoral work examines adjusting treatment according to observed tumour response. Adaptive approaches respond to the evolution tumours undergo.

Biomarker Guided Treatment

Research examines molecular markers directing treatment selection for patients. Marker guided selection avoids treatments unlikely to provide benefit.

Molecularly Selected Trials

Doctoral study examines trials enrolling patients by molecular characteristics. Molecular selection concentrates benefit within tested populations.

Adaptive Trial Design Research

Research examines trial designs testing several treatments or tumour types together. Efficient designs matter greatly where patient numbers are limited.

Window Of Opportunity Trials

Doctoral work examines treatment given briefly before planned tumour surgery. Removed tissue then reveals whether treatment reached and affected the tumour.

Early Phase Trial Research

Research examines first studies of new treatments in tumour patients. Early trials must balance scientific learning against participant burden.

Trial Endpoint Research

Doctoral study examines what outcomes tumour trials should actually measure. Endpoint choice determines whether trials detect meaningful benefit.

Surrogate Endpoint Research

Research examines whether early measures reliably predict survival benefit. Surrogate measures in this field predict survival inconsistently.

Preclinical Model Research

Doctoral work examines laboratory models used to test candidate treatments. Model choice largely determines whether findings transfer to patients.

Patient Derived Model Research

Research examines laboratory models grown directly from patient tumours. Patient derived models preserve the diversity that established lines lose.

Model Translation Research

Doctoral study examines why laboratory successes fail in human patients. Translation failure in this field is frequent and remains poorly explained.

Symptom Management Research

Research examines relieving symptoms experienced by brain tumour patients. Symptom control affects daily life more than tumour measurements do.

Seizure Management Research

Doctoral work examines seizures occurring in patients with brain tumours. Seizures are common and substantially affect independence and driving.

Cerebral Swelling Management

Research examines managing fluid accumulation surrounding brain tumours. Swelling causes many of the symptoms and responds rapidly to treatment.

Steroid Use Research

Doctoral study examines steroid treatment used to reduce brain swelling. Steroids relieve symptoms quickly and cause substantial cumulative harm.

Thrombosis Management Research

Research examines blood clots that frequently affect brain tumour patients. Treatment must balance clot risk against bleeding within the tumour.

Fatigue Research

Doctoral work examines profound tiredness reported by tumour patients. Fatigue is the most commonly reported and least effectively treated symptom.

Cognitive Impairment Research

Research examines thinking difficulties caused by tumours and their treatment. Cognitive change affects work, relationships and independent living.

Neurocognitive Assessment Research

Doctoral study examines measuring cognitive function in tumour patients. Assessment must be brief enough for patients who tire very quickly.

Cognitive Rehabilitation Research

Research examines interventions supporting thinking ability after treatment. Rehabilitation is under provided despite substantial patient need.

Language Function Research

Doctoral work examines speech and language affected by tumours and surgery. Language difficulty profoundly affects relationships and daily independence.

Motor Function Research

Research examines movement difficulties caused by tumours and their treatment. Movement problems determine independence and need for daily support.

Rehabilitation Research

Doctoral study examines rehabilitation for patients with nervous system tumours. Rehabilitation improves function even where the tumour progresses.

Quality Of Life Research

Research examines daily life for people living with nervous system tumours. Quality of life matters as much to patients as duration of survival.

Patient Reported Outcome Research

Doctoral work examines outcomes reported directly by tumour patients. Cognitive difficulty complicates self reporting in this particular population.

Caregiver Research

Research examines experiences of family members supporting tumour patients. Caregivers face very high burden and receive comparatively little support.

Psychological Support Research

Doctoral study examines psychological care for patients and their families. Distress is very common and frequently goes entirely unaddressed.

Prognosis Communication Research

Research examines discussing likely outcome with patients and families. These conversations are difficult and are remembered for a lifetime.

Advance Care Planning Research

Doctoral work examines planning future care while patients can still decide. Cognitive decline makes early planning particularly important here.

Palliative Care Research

Research examines comfort focused care alongside tumour directed treatment. Early palliative involvement improves both experience and sometimes survival.

End Of Life Care Research

Doctoral study examines care during the final period of a patient illness. Brain tumour patients frequently lose capacity before this period begins.

Bereavement Research

Research examines supporting families after the death of a tumour patient. Support needs continue long after contact with services has fully ended.

Survivorship Research

Doctoral work examines long term life after nervous system tumour treatment. Survivors face lasting consequences that services address poorly.

Late Effect Research

Research examines consequences emerging long after treatment has finished. Late effects include hormonal, cognitive and further tumour risks.

Return To Work Research

Doctoral study examines patients resuming employment after tumour treatment. Employment supports identity, income and psychological wellbeing together.

Childhood Survivor Research

Research examines adults who received brain tumour treatment as children. Childhood survivors face lifelong consequences requiring continued specialist care.

Epidemiology Research

Doctoral work examines how frequently nervous system tumours occur in populations. Occurrence patterns inform both service planning and cause research.

Risk Factor Research

Research examines exposures possibly associated with brain tumour development. Established causes are few and explain a small share of cases.

Registry Research

Doctoral study examines national datasets recording tumour diagnosis and outcome. Registries reveal variation that individual centres cannot detect.

Real World Outcome Research

Research examines outcomes in routine practice beyond controlled clinical trials. Routine populations are older and frailer than trial participants are.

Care Pathway Research

Doctoral work examines routes patients follow through tumour care services. Pathway design determines both treatment speed and continuity of care.

Centralisation Research

Research examines concentrating tumour treatment within specialist centres. Concentration improves outcomes while increasing travel burden for families.

Access To Trials Research

Doctoral study examines who is offered participation in tumour clinical trials. Trial access differs sharply by geography, age and treating centre.

Health Inequality Research

Research examines unequal tumour outcomes between differing population groups. Differences persist after adjustment for tumour type and patient age.

Global Neuro Oncology

Doctoral work examines tumour care across differing regions of the world. Access to diagnosis and treatment differs enormously between countries.

Low Resource Setting Research

Research examines tumour care where specialist services are severely limited. Many patients worldwide never receive any tumour directed treatment.

Health Economics Research

Doctoral study evaluates value delivered by tumour treatments and services. Economic evidence determines which treatments health systems will fund.

Machine Learning Applications

Research applies learned models across tumour diagnosis and outcome prediction. Learned models require validation on data from separate institutions.

Prediction Model Research

Doctoral work examines models predicting outcome for individual tumour patients. Individual prediction supports treatment discussion and planning.

Model Validation Research

Research examines testing prediction models in independent patient populations. Most published tumour prediction models fail external validation.

Explainability Research

Doctoral study examines making automated conclusions interpretable to clinicians. Clinicians will not act on outputs they cannot interrogate.

Data Sharing Research

Research examines sharing tumour data across institutions and countries. Sharing is essential because individual centres see very few rare tumours.

Tissue Biobanking Research

Doctoral work examines collection and stewardship of donated tumour tissue. Tissue collections underpin nearly all laboratory research in this field.

Research Participation Research

Research examines patients and families shaping the direction of research. Involvement changes which questions researchers actually choose to ask.

Ethics In Neuro Oncology

Doctoral study examines ethical questions raised by tumour care and research. Consent is complicated where the tumour itself affects understanding.

Implementation And Adoption

Research examines why advances are or are not adopted into routine care. Implementation, not discovery, is where most potential benefit is lost.